Andrew Pekosz
Andrew Pekosz
Professor of Molecular Microbiology, Johns Hopkins Bloomberg School of Public Health
Verified email at - Homepage
Cited by
Cited by
Deployment of convalescent plasma for the prevention and treatment of COVID-19
EM Bloch, S Shoham, A Casadevall, BS Sachais, B Shaz, JL Winters, ...
The Journal of clinical investigation 130 (6), 2757-2765, 2020
The Xs and Y of immune responses to viral vaccines
SL Klein, A Jedlicka, A Pekosz
The Lancet infectious diseases 10 (5), 338-349, 2010
IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses
DJ Lenschow, C Lai, N Frias-Staheli, NV Giannakopoulos, A Lutz, T Wolff, ...
Proceedings of the National Academy of Sciences 104 (4), 1371-1376, 2007
Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins
J Zhang, A Pekosz, RA Lamb
Journal of virology 74 (10), 4634-4644, 2000
Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells
A Ibricevic, A Pekosz, MJ Walter, C Newby, JT Battaile, EG Brown, ...
Journal of virology 80 (15), 7469-7480, 2006
Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model
TE Sussan, S Gajghate, RK Thimmulappa, J Ma, JH Kim, K Sudini, ...
PloS one 10 (2), e0116861, 2015
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
SL Klein, A Pekosz, HS Park, RL Ursin, JR Shapiro, SE Benner, ...
The Journal of clinical investigation 130 (11), 6141-6150, 2020
Efficacy of antibodies and antiviral drugs against Covid-19 Omicron variant
E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito, ...
New England Journal of Medicine 386 (10), 995-998, 2022
Influenza A Virus M2 Ion Channel Activity Is Essential for Efficient Replication in Tissue Culture
M Takeda, A Pekosz, K Shuck, LH Pinto, RA Lamb
Journal of virology 76 (3), 1391-1399, 2002
Efficacy of antibodies and antiviral drugs against Omicron BA. 2.12. 1, BA. 4, and BA. 5 subvariants
E Takashita, S Yamayoshi, V Simon, H Van Bakel, EM Sordillo, A Pekosz, ...
New England Journal of Medicine 387 (5), 468-470, 2022
Distinct domains of the influenza a virus M2 protein cytoplasmic tail mediate binding to the M1 protein and facilitate infectious virus production
MF McCown, A Pekosz
Journal of virology 80 (16), 8178-8189, 2006
COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva
N Pisanic, PR Randad, K Kruczynski, YC Manabe, DL Thomas, A Pekosz, ...
Journal of clinical microbiology 59 (1), 10.1128/jcm. 02204-20, 2020
The Influenza A Virus M2 Cytoplasmic Tail Is Required for Infectious Virus Production and Efficient Genome Packaging
MF McCown, A Pekosz
Journal of virology 79 (6), 3595-3605, 2005
Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells
A Krug, R Veeraswamy, A Pekosz, O Kanagawa, ER Unanue, M Colonna, ...
The Journal of experimental medicine 197 (7), 899-906, 2003
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
H Kared, AD Redd, EM Bloch, TS Bonny, H Sumatoh, F Kairi, D Carbajo, ...
The Journal of clinical investigation 131 (5), 2021
Antigen-based testing but not real-time polymerase chain reaction correlates with severe acute respiratory syndrome coronavirus 2 viral culture
A Pekosz, V Parvu, M Li, JC Andrews, YC Manabe, S Kodsi, DS Gary, ...
Clinical Infectious Diseases 73 (9), e2861-e2866, 2021
Early outpatient treatment for Covid-19 with convalescent plasma
DJ Sullivan, KA Gebo, S Shoham, EM Bloch, B Lau, AG Shenoy, ...
New England Journal of Medicine 386 (18), 1700-1711, 2022
The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles
SR Schaecher, JM Mackenzie, A Pekosz
Journal of virology 81 (2), 718-731, 2007
Structure and intracellular targeting of the SARS-coronavirus Orf7a accessory protein
CA Nelson, A Pekosz, CA Lee, MS Diamond, DH Fremont
Structure 13 (1), 75-85, 2005
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers
EU Patel, EM Bloch, W Clarke, YH Hsieh, D Boon, Y Eby, RE Fernandez, ...
Journal of Clinical Microbiology 59 (2), 10.1128/jcm. 02257-20, 2021
The system can't perform the operation now. Try again later.
Articles 1–20